Heartflow Launches NAVIGATE-PCI Registry to Assess AI-Guided PCI Planning in 2,500 Patients
Reuters
Oct 22, 2025
Heartflow Launches NAVIGATE-PCI Registry to Assess AI-Guided PCI Planning in 2,500 Patients
Heartflow Inc. has announced new developments in clinical research and product offerings related to coronary intervention planning. The company's PLAN CALCIUM study evaluated the impact of integrating Heartflow Plaque Analysis with coronary CTA imaging and FFRCT analysis to inform interventional cardiologists' decisions on percutaneous coronary intervention $(PCI)$ in patients with highly calcified lesions. Data from the PLAN CALCIUM study will be presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2025 conference, scheduled for October 26, 2025. Additionally, Heartflow will initiate the NAVIGATE-PCI Registry in 2026, enrolling approximately 2,500 patients across 30 U.S. sites. This registry will assess the effect of the company's PCI Navigator tool on physician confidence, procedural safety, efficiency, strategy, and patient outcomes compared to standard care. Heartflow will also demonstrate PCI Navigator at their exhibit booth during the TCT 2025 conference.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heartflow Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9549915-en) on October 22, 2025, and is solely responsible for the information contained therein.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.